Motilal Oswal Invests $72M in Sensa Core to Boost India's Medtech Manufacturing

• Motilal Oswal Alternates invested $72 million in Hyderabad-based medtech Sensa Core for a significant minority stake.
• The investment aims to fuel Sensa Core's global ambitions and accelerate indigenous medical device manufacturing in India.
• Founded by Dr. Ravi Kumar Meruva, Sensa Core dominates the domestic electrolyte analyser market and exports to 78 countries.
• Funds will bankroll capacity expansion at a new facility in Hyderabad’s Medical Device Park for next-gen products.
• The move supports India's goal to reduce reliance on medical device imports, which currently exceed 75% annually.

Why It Matters: Motilal Oswal's $72M investment in Sensa Core aims to boost indigenous medtech and global reach.